Selective activity of polyene macrolides produced by genetically modified Streptomyces on Trypanosoma cruzi

International Journal of Antimicrobial Agents

Volumn 28, Issue 2, 2006, Pages 104-109

  Rolón, Miriam ^a   Seco, Elena M ^b   Vega, Celeste ^a   Nogal, Juan J ^a   Escario, José A ^a   Gómez Barrio, Alicia ^a   Malpartida, Francisco ^b  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

Author keywords

Pimaricin; Polyene amides; Trypanosoma; Trypanosoma cruzi

Indexed keywords

AMIDE; AMPHOTERICIN B; ANTITRYPANOSOMAL AGENT; MACROLIDE; POLYENE ANTIBIOTIC AGENT;

AMASTIGOTE; ANIMAL CELL; ARTICLE; CELL LINE; CELL PROLIFERATION; DRUG ACTIVITY; DRUG EFFICACY; DRUG POTENCY; EPIMASTIGOTE; FIBROBLAST; GENETIC ANALYSIS; IN VITRO STUDY; MAMMAL CELL; NONHUMAN; PRIORITY JOURNAL; STREPTOMYCES; TRYPANOSOMA CRUZI;

AMPHOTERICIN B; ANIMALS; CELL LINE; CHAGAS DISEASE; FIBROBLASTS; MACROLIDES; MACROPHAGES; MALE; MICE; MONOSACCHARIDES; NATAMYCIN; PARASITIC SENSITIVITY TESTS; POLYENES; STREPTOMYCES; TRYPANOCIDAL AGENTS; TRYPANOSOMA CRUZI;

EID: 33746300777     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2006.02.025     Document Type: Article

References (33)

1. Opperdoes F.R. The Trypanosomatidae: amazing organisms. J Bioenerg Biomembr 26 (1994) 145-146
2. Control of Chagas disease. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 1991;811:1-95.
3. Croft S.L., Urbina J.A., and Brun R. Chemotherapy of human leishmaniasis and trypanosomiasis. In: Hide G., Mottram J.C., Coombs G.H., et al. (Eds). Trypanosomiasis and leishmaniasis: biology and control (1997), CAB International, Wallington, UK 245-257
4. Liendo A., Lazardi K., and Urbina J.A. In-vitro antiproliferative effects and mechanism of action of the bis-triazole D0870 and its S(-) enantiomer against Trypanosoma cruzi. J Antimicrob Chemother 41 (1998) 197-205
5. Maldonado R.A., Molina J., Payares G., and Urbina J.A. Experimental chemotherapy with combinations of ergosterol biosynthesis inhibitors in murine models of Chagas' disease. Antimicrob Agents Chemother 37 (1993) 1353-1359
6. Urbina J.A., Payares G., Contreras L.M., et al. Antiproliferative effects and mechanism of action of SCH 56592 against Trypanosoma (Schizotrypanum) cruzi: in vitro and in vivo studies. Antimicrob Agents Chemother 42 (1998) 1771-1777
7. Boyle F.T., Gilman D.J., Gravestock M.B., and Wardleworth J.M. Synthesis and structure-activity relationships of a novel antifungal agent, ICI 195,739. Ann N Y Acad Sci 544 (1988) 86-100
8. Brener Z., Cancado J.R., Galvao L.M., et al. An experimental and clinical assay with ketoconazole in the treatment of Chagas disease. Mem Inst Oswaldo Cruz 88 (1993) 149-153
9. Urbina J.A., Machin I., and Jurado L. The limitations of paradigms: studies on the intermediary metabolism of Trypanosoma cruzi. Biol Res 26 (1993) 81-88
10. de Castro S.L. The challenge of Chagas' disease chemotherapy: an update of drugs assayed against Trypanosoma cruzi. Acta Trop 53 (1993) 83-98
11. Herwaldt B.L. Leishmaniasis. Lancet 354 (1999) 1191-1199
12. Yardley V., and Croft S.L. In vitro and in vivo activity of amphotericin B-lipid formulations against experimental Trypanosoma cruzi infections. Am J Trop Med Hyg 61 (1999) 193-197
13. Gil J.A., and Martín J.F. Polyene antibiotics. In: Strohl W.R. (Ed). Biotechnology of antibiotics (1997), Marcel Dekker, New York, NY 551-575
14. Adjou K.T., Demaimay R., Deslys J.P., et al. MS-8209, a water-soluble amphotericin B derivative, affects both scrapie agent replication and PrPres accumulation in Syrian hamster scrapie. J Gen Virol 80 (1999) 1079-1085
15. Chéron M., Cybulska B., Mazerski J., et al. Quantitative structure-activity relationships in amphotericin B derivatives. Biochem Pharmacol 37 (1988) 827-836
16. Cybulska B., Bolard J., Seksek O., et al. Identification of the structural elements of amphotericin B and other polyene macrolide antibiotics of the hepteane group influencing the ionic selectivity of the permeability pathways formed in the red cell membrane. Biochim Biophys Acta 1240 (1995) 167-178
17. Cybulska B., Gadomska I., Mazerski J., et al. N-Methyl-N-d-fructosyl amphotericin B methyl ester (MF-AME), a novel antifungal agent of low toxicity: monomer/micelle control over selective toxicity. Acta Biochim Pol 47 (2000) 121-131
18. Graybill J.R., Najvar L.K., Fothergill A., et al. KY-62, a polyene analog of amphotericin B, for treatment of murine candidiasis. Antimicrob Agents Chemother 42 (1998) 147-150
19. Mazerski J., Bolard J., and Borowski E. Effect of the modifications of ionizable groups of amphotericin B on its ability to form complexes with sterols in hydroalcoholic media. Biochim Biophys Acta 1236 (1995) 170-176
20. Parmegiani R.M., Loebenberg D., Antonacci B., et al. Comparative in vitro and in vivo evaluation of N-d-ornithyl amphotericin B methyl ester, amphotericin B methyl ester, and amphotericin B. Antimicrob Agents Chemother 31 (1987) 1756-1760
21. Szlinder-Richert J., Mazerski J., Cybulska B., et al. MFAME, N-methyl-N-d-fructosyl amphotericin B methyl ester, a new amphotericin B derivative of low toxicity: relationship between self-association and effects on red blood cells. Biochim Biophys Acta 1528 (2001) 15-24
22. Pérez-Zúñiga F.J., Seco E.M., Cuesta T., et al. CE-108, a new macrolide tetraene antibiotic. J Antibiot (Tokyo) 57 (2004) 197-204
23. Seco E.M., Pérez-Zuñiga F.J., Rolón M.S., and Malpartida F. Starter unit choice determines the production of two tetraene macrolides, rimocidin and CE-108, in Streptomyces diastaticus var. 108. Chem Biol 11 (2004) 357-366
24. Seco E.M., Fotso S., Laatsch H., and Malpartida F. A tailoring activity is responsible for generating polyene amide derivatives in Streptomyces diastaticus var. 108. Chem Biol 12 (2005) 1093-1101
25. Seco E.M., Cuesta T., Fotso S., et al. Two polyene amides produced by genetically modified Streptomyces diastaticus var. 108. Chem Biol 12 (2005) 535-543
26. Buckner F.S., Verlinde C.L., La Flamme A.C., and Van Voorhis W.C. Efficient technique for screening drugs for activity against Trypanosoma cruzi using parasites expressing beta-galactosidase. Antimicrob Agents Chemother 40 (1996) 2592-2597
27. Le Senne A., Muelas-Serrano S., Fernandez-Portillo C., et al. Biological characterization of a beta-galactosidase expressing clone of Trypanosoma cruzi CL strain. Mem Inst Oswaldo Cruz 97 (2002) 1101-1105
28. Vega C., Rolón M., Martínez-Fernández A.R., et al. A new pharmacological screening assay with Trypanosoma cruzi epimastigotes expressing beta-galactosidase. Parasitol Res 95 (2005) 296-298
29. Nakayama G.R., Caton M.C., Nova M.P., and Parandoosh Z. Assessment of the Alamar Blue assay for cellular growth and viability in vitro. J Immunol Methods 204 (1997) 205-208
30. O'Brien J., Wilson I., Orton T., and Pognan F. Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur J Biochem 267 (2000) 5421-5426
31. Urbina J.A. Chemotherapy of Chagas disease. Curr Pharm Des 8 (2002) 287-295
32. de Castro S.L., Soeiro M.N., Higashi K.O., and Meirelles M.N. Differential effect of amphotericin B on the three evolutive stages of Trypanosoma cruzi and on the host cell-parasite interaction. Braz J Med Biol Res 26 (1993) 1219-1229
33. Hammond S.M. Biological activity of polyene antibiotics. Prog Med Chem 14 (1977) 105-179